Mumbai, Oct. 30 -- Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Venetoclax Tablets, 10 mg, 50 mg and 100 mg.

Published by HT Digital Content Services with permission from Capital Market....